Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | VCAM1 | P19320 | 2/20 | 0.77 |
| ▸ | CASP6 | P55212 | 1/20 | 0.70 |
| ▸ | MEN1 | O00255 | 3/20 | 0.68 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.68 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.68 |
| ▸ | TSHR | P16473 | 3/20 | 0.64 |
| ▸ | LMNA | P02545 | 2/20 | 0.64 |
| ▸ | MAPT | P10636 | 2/20 | 0.59 |
| ▸ | RAF1 | P04049 | 1/20 | 0.59 |
| ▸ | HPGD | P15428 | 1/20 | 0.59 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.59 |
| ▸ | GFER | P55789 | 1/20 | 0.59 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.59 |
| ▸ | HCAR3 | P49019 | 2/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 4-Chloro-3-Nitrobenzoic Acid SCHEMBL30234086 | 1.00 | VCAM1 (0.77) | VCAM1CASP6MEN1KMT2AALDH1A1 | |
| 4-Chloro-3-Nitrobenzoic Acid SCHEMBL10608947 | 0.98 | VCAM1 (0.74) | VCAM1CASP6MEN1KMT2AALDH1A1 | |
| 4-Chloro-3-Nitrobenzoic Acid SCHEMBL28165768 | 0.98 | VCAM1 (0.74) | VCAM1CASP6MEN1KMT2AALDH1A1 | |
| 4-Chloro-3-Nitrobenzoic Acid SCHEMBL10608939 | 0.98 | VCAM1 (0.74) | VCAM1CASP6MEN1KMT2AALDH1A1 | |
| 4-Chloro-3-Nitrobenzoic Acid SCHEMBL8028245 | 0.98 | VCAM1 (0.74) | VCAM1CASP6MEN1KMT2AALDH1A1 | |
| 4-Chloro-3-Nitrobenzoic Acid SCHEMBL8743988 | 0.91 | VCAM1 (0.64) | VCAM1CASP6MEN1KMT2AALDH1A1 | |
| SCHEMBL1258621 | 0.87 | VCAM1 (1.00) | VCAM1MEN1KMT2AALDH1A1KDM4E | |
| SCHEMBL4064668 | 0.86 | VCAM1 (0.72) | VCAM1CASP6MEN1KMT2AALDH1A1 | |
| SCHEMBL4064663 | 0.86 | VCAM1 (0.72) | VCAM1CASP6MEN1KMT2AALDH1A1 | |
| SCHEMBL360051 | 0.85 | CASP6 (0.70) | VCAM1CASP6MEN1KMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1253 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116338060-B | Determination method of genotoxic impurities in chemical bulk drug containing amino | 成都硕德药业有限公司 | 2025-06-03 | — | — | CN | claimed |
| WO-2025087033-A1 | COMPOUND CONTAINING (1,3,4-THIADIAZOLE)BENZENE-1,2-ETHYLENEDIAMINE, PREPARATION METHOD THEREFOR AND USE THEREOF | 中国海洋大学 | 2025-05-01 | — | — | WO | claimed |
| CN-119793527-A | Regeneration method of metal modified mordenite catalyst for methanol amination reaction | 湖北三峡实验室 | 2025-04-11 | — | — | CN | claimed |
| CN-111465699-B | Method for producing amines from carbonyl compounds by transaminase reaction under salt precipitation | 恩齐米克斯公司 | 2024-09-20 | — | — | CN | claimed |
| US-12018303-B2 | Method for preparing amines from carbonyl compounds by transaminase reaction under salt precipitation | ENZYMICALS AG (DE) | 2024-06-25 | — | — | US | claimed |
| CN-117567390-A | Benzene-1, 2-ethylenediamine compound containing (1, 3, 4-thiadiazole) and preparation method and application thereof | 中国海洋大学 | 2024-02-20 | — | — | CN | claimed |
| CN-114195644-B | Process and device for selectively nitrifying p-chlorobenzoic acid | 浙江工业大学 | 2023-11-14 | — | — | CN | claimed |
| CN-116947732-A | Synthesis method of Nidaminib intermediate | 江苏阿尔法药业股份有限公司 | 2023-10-27 | — | — | CN | claimed |
| CN-116730855-B | Synthesis method of 3-amino-4-hexadecyl chlorobenzoate | 苏州开元民生科技股份有限公司 | 2023-10-20 | — | — | CN | claimed |
| CN-116730855-A | Synthesis method of 3-amino-4-hexadecyl chlorobenzoate | 苏州开元民生科技股份有限公司 | 2023-09-12 | — | — | CN | claimed |
| EP-0751768-A1 | ANTI-VIRAL AND ANTI-CANCER AGENTS | RADOPATH LIMITED (GB) | 1997-01-08 | — | — | EP | claimed |
| WO-1996029067-A1 | ANTI-VIRAL AND ANTI-CANCER AGENTS | RADOPATH LIMITED (GB) | 1996-09-26 | — | — | WO | claimed |
| EP-0677292-A1 | Anti-viral and anti-cancer agents | RADOPATH LIMITED (GB) | 1995-10-18 | — | — | EP | claimed |
| WO-1995024897-A1 | ANTI-VIRAL AND ANTI-CANCER AGENTS | RADOPATH LIMITED (GB) | 1995-09-21 | — | — | WO | claimed |
| US-5277790-A | Non-cyanide electroplating solution for gold or alloys thereof | TECHNIC INCORPORATED (US) | 1994-01-11 | — | — | US | claimed |
| EP-0519971-A1 | NOVEL PHARMACEUTICALLY ACTIVE COMPOUNDS WHICH CAN BE FORMED FROM 1,3,4,6,7,8-HEXAHYDRO-2H-PYRIMIDO-(1,2-a)-PYRIMIDINE. | EEC PHARMA SA (FR) | 1992-12-30 | — | — | EP | claimed |
| WO-1991013886-A1 | NOVEL PHARMACEUTICALLY ACTIVE COMPOUNDS WHICH CAN BE FORMED FROM 1,3,4,6,7,8-HEXAHYDRO-2H-PYRIMIDO-(1,2-a)-PYRIMIDINE | EEC-PHARMA S.A. (FR) | 1991-09-19 | — | — | WO | claimed |
| US-4421694-A | Process for the preparation of nitroanilines | BAYER AKTIENGESELLSCHAFT (DE) | 1983-12-20 | — | — | US | claimed |
| US-4152160-A | PHOTOTHERMOGRAPHY, SILVER BEHENATE | FUJI PHOTO FILM CO., LTD. (JP) | 1979-05-01 | — | — | US | claimed |
| US-3997342-A | Photoconductive element exhibiting persistent conductivity | EASTMAN KODAK COMPANY (US) | 1976-12-14 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12018303-B2 | Method for preparing amines from carbonyl compounds by transaminase reaction under salt precipitation | GOT1, GOT2, OAT | VCAM1 4412/4885CASP6 2918/4885MEN1 2979/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.